Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2023. Start Trial.
Date Value
September 30, 2026 101.27M
June 30, 2026 88.49M
March 31, 2026 75.23M
December 31, 2025 79.16M
September 30, 2025 74.62M
June 30, 2025 72.10M
Date Value
March 31, 2025 68.77M
December 31, 2024 57.42M
September 30, 2024 49.92M
June 30, 2024 42.24M
March 31, 2024 34.32M
December 31, 2023 28.53M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Ligand Pharmaceuticals, Inc. 23.09M
Xeris Biopharma Holdings, Inc. 38.38M
ANI Pharmaceuticals, Inc. 50.60M
Corcept Therapeutics, Inc. 241.72M
Veru, Inc. 11.76M